Cargando…

Posterior scleritis after biweekly aflibercept intravitreal injections

PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hébert, Mélanie, You, Eunice, Gravel, Jean-François, Dirani, Ali, Bourgault, Serge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474326/
https://www.ncbi.nlm.nih.gov/pubmed/36118279
http://dx.doi.org/10.1016/j.ajoc.2022.101696
_version_ 1784789691953840128
author Hébert, Mélanie
You, Eunice
Gravel, Jean-François
Dirani, Ali
Bourgault, Serge
author_facet Hébert, Mélanie
You, Eunice
Gravel, Jean-François
Dirani, Ali
Bourgault, Serge
author_sort Hébert, Mélanie
collection PubMed
description PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe pain, photophobia, and tearing. Ophthalmological examination revealed choroidal folds and B-scan ultrasound confirmed significant thickening of the sclera, leading to a diagnosis of posterior scleritis. This resolved under topical and systemic corticosteroids. CONCLUSIONS AND IMPORTANCE: Intravitreal anti-VEGF injections could be associated with non-infectious posterior scleritis. Clinicians should be particularly aware of this possibility in patients receiving frequent injections.
format Online
Article
Text
id pubmed-9474326
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94743262022-09-16 Posterior scleritis after biweekly aflibercept intravitreal injections Hébert, Mélanie You, Eunice Gravel, Jean-François Dirani, Ali Bourgault, Serge Am J Ophthalmol Case Rep Case Report PURPOSE: To describe a case of posterior scleritis following anti-vascular endothelial growth factor (VEGF) injection. OBSERVATIONS: A 51-year-old male receiving biweekly anti-VEGF injections for a central retinal vein occlusion complicated with cystoid macular edema presented with new-onset severe pain, photophobia, and tearing. Ophthalmological examination revealed choroidal folds and B-scan ultrasound confirmed significant thickening of the sclera, leading to a diagnosis of posterior scleritis. This resolved under topical and systemic corticosteroids. CONCLUSIONS AND IMPORTANCE: Intravitreal anti-VEGF injections could be associated with non-infectious posterior scleritis. Clinicians should be particularly aware of this possibility in patients receiving frequent injections. Elsevier 2022-09-06 /pmc/articles/PMC9474326/ /pubmed/36118279 http://dx.doi.org/10.1016/j.ajoc.2022.101696 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Hébert, Mélanie
You, Eunice
Gravel, Jean-François
Dirani, Ali
Bourgault, Serge
Posterior scleritis after biweekly aflibercept intravitreal injections
title Posterior scleritis after biweekly aflibercept intravitreal injections
title_full Posterior scleritis after biweekly aflibercept intravitreal injections
title_fullStr Posterior scleritis after biweekly aflibercept intravitreal injections
title_full_unstemmed Posterior scleritis after biweekly aflibercept intravitreal injections
title_short Posterior scleritis after biweekly aflibercept intravitreal injections
title_sort posterior scleritis after biweekly aflibercept intravitreal injections
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9474326/
https://www.ncbi.nlm.nih.gov/pubmed/36118279
http://dx.doi.org/10.1016/j.ajoc.2022.101696
work_keys_str_mv AT hebertmelanie posteriorscleritisafterbiweeklyafliberceptintravitrealinjections
AT youeunice posteriorscleritisafterbiweeklyafliberceptintravitrealinjections
AT graveljeanfrancois posteriorscleritisafterbiweeklyafliberceptintravitrealinjections
AT diraniali posteriorscleritisafterbiweeklyafliberceptintravitrealinjections
AT bourgaultserge posteriorscleritisafterbiweeklyafliberceptintravitrealinjections